RADX · Radiopharm Theranostics Ltd
Market Cap
$34.84M
Shares
14.46M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.28
Open$2.37
Day$2.19–2.44
52W close$2.26–10.63
Avg vol 30d130K
Short int27K · 0.2% float · 1.0d
Short vol60%
DataDec 2024–Aug 2026
Up next
FQ1-27 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.70
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−49%
below
Price vs 50-day avg
−34%
below
RSI (14)
30
neutral
MACD trend
Positive
52-week position
0%
near low
Momentum
relative strength
1-month return
−27%
trailing
6-month return
−54%
trailing
YTD return
−56%
this year
Relative strength
−68%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $3 › 200d $4 — 200d above 50d
Institutional flow
Flat
0% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.19% of float · ▼ -63.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
7 holders — mid 1-yr range
Squeeze score
32
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
169%
annualized · 1-yr
Max drawdown
−79%
past year
ATR
12.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−49%
Bearish
Price vs 50-day avg
−34%
Bearish
RSI (14)
30
Neutral
MACD trend
Positive
Bullish
52-week position
0%
Bearish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $3 › 200d $4 — 200d above 50d
Institutional flow
Flat
0% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.19% of float · ▼ -63.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
7 holders — mid 1-yr range
Price context
position in its 52-week range
Range low $2
Now $2 · 0%
Range high $11
vs 200-day avg -49%
vs 50-day avg -34%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RADX
this stock
Radiopharm Theranostics Ltd
|
$34.84M | -56.3% | — | — | 0.2% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$137.30B | +20.1% | +46.2% | 31.6 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$81.77B | +3.5% | +20.8% | 19.7 | 2.3% |
|
ARGX
Argenx SE
|
$64.16B | +22.7% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$59.51B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
7
- % held
- 353.6%
- Net QoQ
- -182.7K sh
- Top holder
- Stonepine Capital Managem…
Held
Float
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RADX | -6.6% | -26.7% | -54.3% | -27.6% | -56.3% |
| SPY | +0.5% | +1.2% | +13.3% | +2.7% | +12.5% |
| vs SPY | -7.0% | -27.9% | -67.6% | -30.3% | -68.8% |